We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $42.1M invested in Zealand Pharma A/S American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
17% less capital invested
Capital invested by funds: $50.5M → $42.1M (-$8.39M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$532K |
| 2 |
AIC
AWM Investment Company
New York
|
+$118K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$24.5K |
| 4 |
Morgan Stanley
New York
|
+$11.2K |
| 5 |
JP Morgan Chase
New York
|
+$8.84K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$689K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$250K |
| 3 |
Millennium Management
New York
|
-$171K |
| 4 |
Jane Street
New York
|
-$166K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$12K |